Skip to main content
Log in

Economic burden of HIV/AIDS “substantial” in the US

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Hutchinson AB, Farnham PG, Dean HD, Ekwueme DU, Del Rio C, Kamimoto L, Kellerman SE.The economic burden of HIV in the United States in the era of highly active antiretroviral therapy: evidence of continuing racial and ethnic differences. JAIDS 43: 451-457, No. 4, 1 Dec 2006

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Economic burden of HIV/AIDS “substantial” in the US. Pharmacoecon. Outcomes News 521, 9 (2007). https://doi.org/10.2165/00151234-200705210-00029

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705210-00029

Keywords

Navigation